Market Tracker

08/22 6:05pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

5.22
Data as of Aug 22
 +0.36 / +7.41%
Today’s Change
4.28
Today|||52-Week Range
19.11
-35.40%
Year-to-Date

Today’s Trading

Previous close4.86
Today’s open4.80
Day’s range4.74 - 5.37
Volume629,489
Average volume (3 months)672,001
Market cap$107.1M
Dividend yield--
Data as of 3:59pm ET, 08/22/2014

Growth & Valuation

Earnings growth (last year)-80.56%
Earnings growth (this year)-31.69%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
QTNTQuotient Ltd+0.10+1.14%
CGIXCancer Genetics Inc-0.07-0.79%
ERBERBA Diagnostics Inc0.000.00%
TROVTrovagene Inc+0.08+1.97%
Data as of 4:00pm ET, 08/22/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$0.00
Annual profit (last year)-$21.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts